Chronic immune thrombocytopentic purpura in children: assessment of rituximab treatment.
Taube
Tillmann
T
von Stackelberg
Arend
A
Schulte-Overberg
Ursula
U
Henze
Günter
G
Schmid
Hansjörg
H
Reinhard
Harald
H
D000367:Age Factors; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*; D012074:Remission Induction; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab